title: Use of an Acetyl Derivative to Improve GC-MS Determination of Norbuprenorphine in the Presence of High Concentrations of Buprenorphine in Urine.
abstract: Certain patients being treated with Suboxone™ or Subutex™ can exhibit very high buprenorphine and low norbuprenorphine concentrations in urine. Very high buprenorphine can interfere with buprenorphine-D4 used as an internal standard, causing errors in norbuprenorphine determination by gas chromatography-mass spectrometry (GC-MS). We used a modified method of Wu et al. to introduce norbuprenorphine-D3 as a separate internal standard for norbuprenorphine. This allowed us to accurately measure norbuprenorphine in neat urine specimens when buprenorphine is present in extremely high concentrations. Laboratories measuring buprenorphine and metabolite by GC-MS may face this problem if their clientele includes patients being treated with other medications that interfere with the cytochrome p450 CYP 3A4-mediated conversion of buprenorphine to norbuprenorphine.
authors.affiliation: Toxicology, Quest Diagnostics, Marlboro, MA, USA.
authors.forename: Joel R
authors.initials: JR
authors.lastname: Gervais
authors.affiliation: Toxicology, Quest Diagnostics, Inc., 200 Forest St. Marlborough, MA, USA gregory.x.hobbs@questdiagnostics.com.
authors.forename: Gregory A
authors.initials: GA
authors.lastname: Hobbs
mesh_terms: D002047:Buprenorphine / Q000031:analogs & derivatives* / Q000652:urine*; D008401:Gas Chromatography-Mass Spectrometry / Q000379:methods*; D006801:Humans; D057230:Limit of Detection
chemical_list: D002047:Buprenorphine; C043585:norbuprenorphine
references.citation: AIDS. 2006 Mar 21;20(5):783-4
references.pmid: 16514314
references.citation: J Anal Toxicol. 2008 Oct;32(8):626-30
references.pmid: 19007513
references.citation: Drug Alcohol Depend. 2003 May 21;70(2 Suppl):S49-57
references.pmid: 12738350
references.citation: J Pharm Biomed Anal. 2011 Feb 20;54(3):588-91
references.pmid: 20940093
references.citation: Drug Metab Dispos. 1998 Mar;26(3):257-60
references.pmid: 9492389
references.citation: Drug Metab Dispos. 1984 Sep-Oct;12(5):577-81
references.pmid: 6149907
references.citation: J Chromatogr A. 2008 Feb 22;1182(1):93-112
references.pmid: 18215395
references.citation: Forensic Sci Int. 2004 Jul 16;143(2-3):121-5
references.pmid: 15240031
references.citation: Eur J Pharm Biopharm. 2001 Mar;51(2):147-51
references.pmid: 11226822
references.citation: Life Sci. 1997;60(22):1953-64
references.pmid: 9180349
references.citation: J Addict Med. 2007 Jun;1(2):104-10
references.pmid: 21768942
references.citation: J Anal Toxicol. 2007 Sep;31(7):377-82
references.pmid: 17725885
references.citation: Clin Chem. 2009 Jun;55(6):1177-87
references.pmid: 19325013
references.citation: Clin Pharmacokinet. 2003;42(13):1071-88
references.pmid: 14531721
references.citation: J Anal Toxicol. 1999 Jul-Aug;23(4):270-9
references.pmid: 10445490
references.citation: Drugs. 2003;63(16):1679-93; discussion 1694-5
references.pmid: 12904086
references.citation: Drug Metab Dispos. 1998 Aug;26(8):818-21
references.pmid: 9698298
references.citation: Clin Infect Dis. 2006 Dec 15;43 Suppl 4:S216-23
references.pmid: 17109308